The Australian Government Response to the Review of Medicines and Medical Devices Regulation agreed to undertake further reviews to potentially streamline the regulatory framework for low-risk products and increase consumer access to these products.
The further reviews include a review of the regulatory framework for low-risk products and a review of the Scheduling Policy Framework for medicines.
A range of options for the future regulation of low risk products was released for public consultation in early 2017. The consultation examined whether the regulatory oversight applied to a range of products that represent a very low safety risk to consumers was consistent with the principles of best practice regulation, and whether there were any opportunities for streamlining or simplifying current regulatory requirements for these products.
Most of the outcomes from this review are operational however, work continues to reform the regulation of low risk medical devices.
In collaboration with state and territory jurisdictions, changes have been made to create a new Scheduling Policy Framework and Scheduling Handbook.